Nostrum Pharmaceuticals, LLC – Trademark Portfolio

Entity Type: 16

Nostrum Pharmaceuticals, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INSPIRAMASK. The owner is based in New Brunswick, NJ.

11D Jules Lane

New Brunswick, NJ 08901

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Nostrum Pharmaceuticals, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Nostrum Pharmaceuticals, LLC have?

Nostrum Pharmaceuticals, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Nostrum Pharmaceuticals, LLC file in?

Nostrum Pharmaceuticals, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Nostrum Pharmaceuticals, LLC's most well-known trademarks?

Nostrum Pharmaceuticals, LLC's registered trademark portfolio includes well-known marks such as INSPIRAMASK. These are among 1 currently registered trademark in the portfolio.

What is Nostrum Pharmaceuticals, LLC's trademark registration success rate?

Nostrum Pharmaceuticals, LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.